RTOG: Hormone Therapy Increases Survival When Combined With Radiation Therapy
Zaltrap Shows Improvement in Survival In Stage IV Metastatic Colorectal Cancer
Trial: Decitabine Improves Survival in Myeloid Leukemia
Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival
VEGF Levels Can Predict Tumor’s Resistance to Avastin
More Patients Get Screened, Colorectal Death Rates Drop
Revlimid Shows 91 Percent Response in Non-Hodgkin’s
Revlimid Also Demonstrates Response in Mantle Cell
FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response
Overall Cancer Mortality Rates Higher For Men Than Women
New Model For Risk Assessment Includes Alcohol, Exercise, Weight
Researchers Identify Five Genes Associated With Melanoma Risk
Stereotactic Body Radiotherapy Could Improve Overall Survival
CMS Issues Coverage Decision For Provenge in Prostate Cancer
Clinical Trials Approved By NCI CTEP Last Month
Approval Granted For New Formulation of Lupron Depot
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- How will FDA regulate psychedelics?
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- The future of oncology: Early-career scientists need mentorship and a new academic model
- OMB proposal to sideline peer review sparks widespread opposition
Nearly 500,000 public comments flood in—here are some highlights
